Evolution of the Average Target: West Pharmaceutical Services, Inc.

Evolution of the Target Price: West Pharmaceutical Services, Inc.

Changes in Analyst Recommendations: West Pharmaceutical Services, Inc.

09c68cce1d467d248a.8TYy7IDWkVzkrPpa9d6QFo_MO7COMDwpV03CbEyGmKM.iWlWgeGVxAqz3q8rh5Xpdd2TQuXbRnJDYgm1OA7vwciTe3668ozaEq7iyg~5f80e049e0f0caaa958436d1d4d657fb
09-09 UBS Raises Price Target on West Pharmaceutical Services to $415 From $340, Keeps Buy Rating MT
07-27 Evercore ISI Adjusts PT on West Pharmaceutical Services to $425 From $410, Maintains Outperform Rating MT
07-27 BNP Paribas Adjusts PT on West Pharmaceutical Services to $459 From $447, Maintains Outperform Rating MT
07-24 Jefferies & Co Adjusts West Pharmaceutical Services PT to $410 From $365, Maintains Buy Rating MT
07-24 Rothschild & Co Redburn Adjusts West Pharmaceutical Services PT to $410 From $353, Maintains Buy Rating MT
07-24 Deutsche Bank Adjusts West Pharmaceutical Services Price Target to $420 From $405, Maintains Buy Rating MT
07-20 Stephens Adjusts West Pharmaceutical Services Price Target to $410 From $360, Maintains Overweight Rating MT
07-15 TD Cowen Adjusts Price Target on West Pharmaceutical Services to $410 From $365, Maintains Buy Rating MT
07-13 BNP Paribas Initiates West Pharmaceutical Services at Outperform With $447 Price Target MT
07-13 BNP Paribas Initiates West Pharmaceutical Services at Outperform With $447 Price Target MT
07-09 Morgan Stanley Adjusts Price Target on West Pharmaceutical Services to $365 From $325 MT
07-06 Evercore ISI Adjusts Price Target on West Pharmaceutical Services to $410 From $390 MT
07-02 KeyBanc Adjusts PT on West Pharmaceutical Services to $390 From $350, Maintains Overweight Rating MT
06-09 Barclays Upgrades West Pharmaceutical Services to Overweight From Equalweight, Adjusts PT to $400 From $310 MT
05-28 Morgan Stanley Adjusts West Pharmaceutical Services PT to $325 From $315, Keeps Equalweight Rating MT
04-24 Stephens Adjusts Price Target on West Pharmaceutical Services to $360 From $320, Maintains Overweight Rating MT
04-24 Deutsche Bank Adjusts West Pharmaceutical Services PT to $340 From $315, Maintains Buy Rating MT
04-24 Rothschild & Co Redburn Adjusts West Pharmaceutical Services Price Target to $353 From $312, Maintains Buy Rating MT
04-24 Jefferies Adjusts West Pharmaceutical Services Price Target to $365 From $295, Maintains Buy Rating MT
04-24 Citigroup Adjusts West Pharmaceutical Services PT to $400 From $375, Maintains Buy Rating MT
04-24 Evercore ISI Adjusts West Pharmaceutical Services PT to $390 From $320, Maintains Outperform Rating MT
04-24 TD Cowen Adjusts West Pharmaceutical Services PT to $365 From $350, Maintains Buy Rating MT
04-24 Analyst recommendations: IBM, Intel, Tesla, AMD, United Rentals… Zonebourse
04-14 Barclays Adjusts Price Target on West Pharmaceutical Services to $275 From $265, Maintains Equalweight Rating MT
02-17 Rothschild & Co Redburn Adjusts Price Target on West Pharmaceutical Services to $312 From $325, Maintains Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+17.64%
+13%
+19.36%
+7.88%
+33.01%
+7.45%
+38.85%
+10.58%
+20.09%
Average +18.65%
Weighted average by Cap. +17.55%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
366.60USD
Average target price
405.38USD
Spread / Average Target
+10.58%
High Price Target
459.00USD
Spread / Highest target
+25.20%
Low Price Target
340.00USD
Spread / Lowest Target
-7.26%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AAA
  1. Stock Market
  2. Stocks
  3. WST Stock
  4. WST * Stock
  5. Consensus West Pharmaceutical Services, Inc.
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!